Linked from

The 26 pages that link to Metabolic syndrome, each with the reason it gives.

• InsulinRelated: Insulin resistance often links its metabolic abnormalities.

• ObesityRelated: The cluster links excess abdominal fat with several cardiometabolic risks.

• Endocrine systemRelated: Its causes involve interacting hormonal and metabolic pathways that remain under study.

• AntipsychoticRelated: Some antipsychotics increase weight and metabolic risks, making ongoing monitoring important.

• Obstructive sleep apneaRelated: It often coexists with obstructive sleep apnea, amid shared metabolic and cardiovascular risks.

• Insulin resistanceRelated: Insulin resistance is commonly associated with this clustering of metabolic risk factors.

• Adipose tissueRelated: Dysfunctional adipose tissue is associated with insulin resistance and this cluster of risks.

• Erectile dysfunctionRelated: Its vascular and metabolic components are associated with erectile dysfunction.

• Sleep apneaRelated: Sleep apnea often coexists with metabolic risk factors, though the relationship is complex.

• Weight lossRelated: Reducing excess body fat can improve several risk factors grouped under this diagnosis.

• Body mass indexRelated: BMI may flag risk, but metabolic syndrome is assessed through additional clinical measures.

• Klinefelter syndromeRelated: People with Klinefelter syndrome have increased risks for several metabolic health problems.

• Cardiorespiratory fitnessRelated: Fitness relates to metabolic health and can improve with regular exercise.

• Psoriatic arthritisRelated: Its frequent coexistence affects cardiovascular risk and treatment planning.

• Psychiatric medicationRelated: Some antipsychotics can contribute to weight gain and metabolic changes that require monitoring.

• DyslipidemiaRelated: Its characteristic lipid abnormalities are a common context for acquired dyslipidemia.

• AdipocyteRelated: Adipose dysfunction is associated with several features of this syndrome.

• ClozapineRelated: Clozapine can promote weight gain and metabolic changes that require ongoing assessment.

• RisperidoneRelated: Monitoring metabolic health matters during risperidone treatment because antipsychotics can affect weight and metabolism.

• OlanzapineRelated: Olanzapine can increase weight and worsen metabolic risk factors.

• AdipokineRelated: Adipokine imbalance is studied as one link among its metabolic risk factors.

• Hidradenitis suppurativaRelated: It commonly coexists with hidradenitis suppurativa and affects long-term health assessment.

• QuetiapineRelated: Quetiapine can contribute to weight gain and metabolic changes that raise this concern.

• Non-alcoholic fatty liver diseaseRelated: Its features commonly accompany this liver disease and help explain its metabolic setting.

• High cholesterolRelated: It often features high triglycerides and low HDL rather than isolated high LDL.

• Nutritional and Metabolic DiseasesRelated: It shows how several metabolic abnormalities can accumulate in one person.